A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER

被引：0
|
作者：
Patel, Sunil H.
Gabrielson, Andrew T.
Chan, Sin
Schwartz, Deborah
Collins, Connie
Singla, Nirmish
Trock, Bruce
Bivalacqua, Trinity J.
Hahn, Noah
Kates, Max R.
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
10.1097/01.JU.0001008640.01272.9d.14
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP16-14
引用
收藏
页码：E245 / E246
页数：2
相关论文
共 50 条
  • [41] Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
    Han, Mi Ah
    Maisch, Philipp
    Jung, Jae Hung
    Hwang, Jun Eul
    Narayan, Vikram
    Cleves, Anne
    Hwang, Eu Chang
    Dahm, Philipp
    INVESTIGATIVE AND CLINICAL UROLOGY, 2021, 62 (06) : 623 - 630
  • [42] INTRAVESICAL BACILLUS CALMETTE - GUERIN: PATTERNS OF USE AND OUTCOMES FOR NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Huang, Dora
    Khan, Munad
    Azer, Sarah
    Sengupta, Shomik
    Lawrentschuk, Nathan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 48 - 48
  • [43] SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR TREATMENT-NAIVE AND PREVIOUSLY TREATED INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER
    McElree, Ian M.
    Orzel, Joanna
    Steinberg, Ryan L.
    Mott, Sarah L.
    O'Donnell, Michael A.
    Packiam, Vignesh T.
    JOURNAL OF UROLOGY, 2023, 209 : E98 - E99
  • [44] A phase I study of intravesical camrelizumab for BCG failure Non-Muscle Invasive Bladder Cancer (NMIBC)
    Wang, Y.
    Xu, P. H.
    Bian, X. J.
    Lu, X. L.
    Wang, Z.
    Wang, X.
    Yao, X. D.
    Shen, Y. J.
    Ye, D. Y.
    EUROPEAN UROLOGY, 2022, 81 : S251 - S251
  • [45] SWOG S0353: PHASE II TRIAL OF INTRAVESICAL GEMCITABINE IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER WHO RECURRED FOLLOWING AT LEAST TWO PRIOR COURSES OF BCG
    Skinner, Eila C.
    Goldman, Bryan
    Sakr, Wael A.
    Petrylak, Daniel P.
    Lenz, Heinz-Josef
    Lee, Cheryl T.
    Wilson, Shandra S.
    Lerner, Seth P.
    Tangen, Cathy M.
    Thompson, Ian M.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E673 - E673
  • [46] SEQUENTIAL INTRAVESICAL GEMCITABINE-DOCETAXEL VERSUS BACILLUS CALMETTE-GUERIN (BCG) IN THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER: A PRELIMINARY COST-EFFECTIVENESS ANALYSIS
    Bukavina, Laura
    Bell, Spencer
    Packiam, Vignesh
    Smaldone, Marc
    Abosh, Phillip
    Uzzo, Robert
    Kutikov, Alexander
    Correa, Andres
    Magee, Diana
    JOURNAL OF UROLOGY, 2023, 209 : E542 - E542
  • [47] ADJUVANT CANCER PEPTIDE VACCINE TREATMENT WITH INTRAVESICAL BCG THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Obara, Wataru
    Hara, Isao
    Miki, Tsuneharu
    Mimata, Hiromitsu
    Shuin, Taro
    Fujioka, Tomoaki
    JOURNAL OF UROLOGY, 2014, 191 (04): : E570 - E570
  • [48] Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma
    Massari, Michael
    O'Malley, Padraic
    Benidir, Tarik
    Su, Li-Ming
    Gao, Hanzhi
    Crispen, Paul L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (09) : 289e7 - 289e12
  • [49] Mycotic Abdominal Aortic Aneurysm Secondary to BCG Therapy for Non-muscle Invasive Urothelial Carcinoma of the Bladder
    Godard, Levi
    Lee, Linda
    McGuinness, Brandon
    Shirsat, Hemlata
    Hoag, Nathan
    VASCULAR AND ENDOVASCULAR SURGERY, 2023, 57 (07) : 776 - 780
  • [50] ADJUVANT AUTOLOGOUS INTRAVESICAL MACROPHAGE CELL THERAPY VS. BCG FOR NON-MUSCLE INVASIVE BLADDER CANCER: A PHASE II, MULTICENTER, RANDOMIZED TRIAL
    Burger, M.
    Thiounn, N.
    Denzinger, N.
    Malavaud, B.
    Wirth, M.
    Thueroff, J. W.
    Romics, I.
    Colombel, M.
    Solsona, E.
    Tombal, B.
    Sherman, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 285 - 285
12345